DHR - Is Agilent A Buy Before Earnings? Examining The Pros And Cons

2024-05-23 10:56:42 ET

Summary

• Agilent Technologies is a major player in the diagnostics and research industry, with a focus on laboratory-focused solutions.
• The company has shown resilience and strong growth potential, with a positive outlook for future earnings and long-term growth.
• However, there are concerns about the company's valuation and potential market volatility, as well as geopolitical risks in China.

Introduction

One of my favorite industries is the diagnostics & research industry, part of the healthcare sector. In this sector, I own the Danaher Corporation ( DHR ). I have bought Thermo Fisher Scientific ( TMO ) for family accounts and have IDEXX Laboratories ( IDXX ) on my watchlist.

In this case, I listed the biggest, second-biggest-and fourth-biggest players in this industry, respectively....

For further details see: